Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinoma
- JCI Insight. 2025 Feb 25:e187025. doi: 10.1172/jci.insight.187025.
- 1. Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
- 2. Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
- 3. Laboratory of Precision Oncology and Cancer Evolution, Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
- 4. Department of Hepato-pancreato-biliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.
- 5. Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
The functional plasticity of tumor-infiltrating B (TIL-B) cells spans from anti-tumor responses to non-canonical immune suppression. Yet, how tumor microenvironment (TME) influences TIL-B development is still underappreciated. Our current study integrated single cell transcriptomics and BCR (B cell receptor) Sequencing to profile TIL-B phenotypes and clonalities in hepatocellular carcinoma (HCC). Using trajectory and gene regulatory network analysis, we were able to characterize plasma cells, memory and naïve B cells within the HCC TME and further revealed a downregulation of BCR-signaling genes in plasma cells and a subset of inflammatory TNF+ memory B cells. Within the TME, non-switch memory B cell subset acquires an age-associated B cell phenotype (TBET+, CD11c+) and expressed higher levels of PD-L1, CD25 and granzyme B. We further demonstrated that the presence of HCC tumor cells could confer suppressive functions on peripheral blood B cells which in turn, dampen T cell co-stimulation. To the best of our knowledge, these findings represent novel mechanisms of non-canonical immune suppression in HCC. While previous studies identified atypical memory B cells in chronic hepatitis and across several solid Cancer types, we further highlighted their potential role as regulatory B cells (Bregs) within both the TME and peripheral blood of HCC patients.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer